Skip to main content
OpenTrials

Clinical trial condition

Male Urogenital Diseases

Explore clinical trials studying Male Urogenital Diseases. Study availability and eligibility vary by location and protocol.

20,851 public trials 3,480 recruiting studies
Refine in advanced search Browse all conditions

Male Urogenital Diseases trial results

Recruiting

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

NCT06995677

Conditions
Carcinoma, FGFR Gene Alterations, FGFR Gene Amplification, +18 more
Locations
  • Urology Centers of Alabama Homewood, Alabama, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • Tri Valley Urology - Murrieta Murrieta, California, United States
  • Eisenhower Medical Associates Rancho Mirage, California, United States
View all 48 locations
View Trial Details
Recruiting

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

NCT06440005

Conditions
Advanced Cancer, Angiosarcoma, Breast Cancer, +46 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Florida Cancer Specialist Sarasota, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Sarah Cannon Research Center Nashville, Tennessee, United States
View Trial Details
Recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old

NCT07536269

Conditions
Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenogenital Syndrome, +16 more
Locations
  • Neurocrine Clinical Site San Francisco, California, United States
  • Neurocrine Clinical Site Hartford, Connecticut, United States
  • Neurocrine Clinical Site Atlanta, Georgia, United States
  • Neurocrine Clinical Site Chicago, Illinois, United States
View Trial Details
Recruiting

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

NCT06711887

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Circuit Clinical Orchard Park, New York, United States
  • Novartis Investigative Site Belo Horizonte, Minas Gerais, Brazil
  • Novartis Investigative Site Santo André, São Paulo, Brazil
  • Novartis Investigative Site Guangzhou, Guangdong, China
View all 49 locations
View Trial Details

Related conditions